Skip to main content

Advertisement

Log in

Vascular acrosyndromes in young adult population. Definition of clinical symptoms and connections to joint hypermobility

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Objectives

Clinical recognition of vascular acrosyndromes is often challenging. The term Raynaud’s phenomenon (RP) is commonly overused to describe any form of cold-related disorder. This study aims to formally evaluate peripheral vascular symptoms affecting the population, aged ≤ 40 years, and identify any correlations to joint hypermobility (JH).

Patients and methods

Fifty patients (31 males, 19 females) with vasomotor symptoms enrolled in this five-year prospective observational study. Clinical examination by a rheumatologist and a vascular surgeon was performed along with cardiology, echocardiographic and Doppler evaluation. Patients underwent blood cell count, biochemistry, thyroid and selectively immunologic testing. Twenty-four (48%) of them performed nailfold capillaroscopy. The SPSS for Windows, v.17.0, Chicago, USA, was used for the statistical analyses.

Results

Twenty-eight patients (56%) presented with erythromelalgia (EM), 6 (12%) with acrocyanosis (AC) and 9 (18%) as a combination of the above disorder. RP diagnosed in five (10%) while two patients (4%) presented as a mix of EM-RP. There was no correlation with abnormal laboratory tests. Increased incidence of JH was found in EM and AC patients. Among those who were tested with nailfold capillaroscopy, 75% had abnormalities ranged from mild to autoimmune-like diseases.

Conclusions

Erythromelalgia is the commonest functional vasculopathy in young population followed by acrocyanosis and a combination of these conditions. Joint hypermobility is markedly increased, indicating that dysautonomy may be considered the causative factor following a trigger event. Overall, RP was observed in 14% of patients. Clinical recognition of these disorders avoids unnecessary investigation.

Key Points

• Vascular acrosyndromes in young adults are commonly functional disorders resembling vascular algodystrophy induced by thermic stress.

• Dysautonomy of joint hypermobility is the co-factor influencing the appearance of the vascular disorders.

• Raynaud’s phenomenon accounts to approximately 14% of vascular acrosyndromes presented in the young adult population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Graph 1
Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Brand FN, Larson MG, Kannel WB, McGuirk JM (1997) The occurrence of Raynaud’s phenomenon in general population: the Framingham study. Vasc Med 2:296–301

    Article  CAS  Google Scholar 

  2. Kumar P, Galarraga B, Belch JJF (2011) Raynaud’s phenomenon. In: Hochberg MC, Silman J, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology (5th Ed). Mosby Elsevier, Philadelphia, pp 1427–1432

    Chapter  Google Scholar 

  3. Ventura I, Reid P, Jan R (2018) Approach to patients with suspected rheumatic disease. Prim Care Clin Office Pract 45:169–180

    Article  Google Scholar 

  4. Pain CE, Constantin T, Toplak N, Moll M, Iking-Konert C, Piotto DP et al (2016) Raynaud’s syndrome in children: systematic review and development of recommendations for assessment and monitoring. Clin Exp Rheumatol 34 (Suppl 100:200–206

  5. Raynaud M. Local asphyxia and symmetrical gangrene of the extremities. Paris. L. Leclerc; 1862

  6. Klippel JH (1991) Raynaud’s phenomenon. The French tricolor. Arch Intern Med 151:2389–2393

    Article  CAS  Google Scholar 

  7. Valdovionos ST, Landry GJ (2014) Raynaud syndrome. Tech Vasc Interv Radiol 17:241–246

    Article  Google Scholar 

  8. Brennan P, Silman A, Black C, Bernstein R, Coppock J, Maddison P et al (1993) Validity and reliability of three methods used in the diagnosis of Raynaud’s phenomenon. Br J Rheumatol 32:357–361

    Article  CAS  Google Scholar 

  9. Wigley FM (2002) Clinical practice. Raynaud’s phenomenon. N Engl J Med 347:1001–1008

    Article  Google Scholar 

  10. LeRoy EC, Medsger TA Jr. Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 1992;10:485–488

  11. Maricq HR, Weinrich MC (1988) Diagnosis of Raynaud’s phenomenon assisted by color charts. J Rheumatol 15:454–459

    CAS  PubMed  Google Scholar 

  12. Maverakis M, Patel F, Kronenberg DG, Chung L, Fiorentino D, Allanore Y et al (2014) International consensus criteria for the diagnosis of Raynaud’s phenomenon. J Autoimmun 48–49::60–65. https://doi.org/10.1016/j.jaut.2014.01.020

    Article  Google Scholar 

  13. Tang Z, Chen Z, Tang B, Jiang H (2015) Primary erythromelalgia: a review. Orphanet J Rare Dis 10:127. https://doi.org/10.1186/s13023-015-0347-1

    Article  PubMed  PubMed Central  Google Scholar 

  14. Heidrich H (2010) Functional vascular diseases: Raynaud’s syndrome, acrocyanosis and erythromelalgia. Vasa 39:33–41. https://doi.org/10.1024/0301-1526/a000003

    Article  CAS  PubMed  Google Scholar 

  15. Kurklinsky AK, Miller VM, Rooke TW (2011) Acrocyanosis. The Flying Dutchman. Vasc Med 16:288–301

    Article  Google Scholar 

  16. Mann N, King T, Murphy R (2019) Review of primary and secondary erythromelalgia. Clin Exp Dermatol. https://doi.org/10.1111/ced.13891

    Article  CAS  Google Scholar 

  17. Gazit Y, Nahir AM, Grahame R, Jacob G (2003) Dysautonomia in the hypermobility syndrome. Am J Med 115:33–40

    Article  Google Scholar 

  18. Hakim AJ, Grahame R (2004) Non-musculoskeletal symptoms in joint hypermobility syndrome: indirect evidence for autonomic dysfunction. Rheumatology 43:1194–1195

    Article  CAS  Google Scholar 

  19. Haberhauer G, Feytertag J, Hanusch-Enserer U, Dunky A (2000) Joint hypermobility syndrome and bilateral total occlusion of the ulnar arteries presenting as Raynaud’s phenomenon. Clin Exp Rheumatol 18:270–271

    CAS  PubMed  Google Scholar 

  20. Beighton PH, Solomon L, Soskolne CL (1973) Articular mobility in an African population. Ann Rheum Dis 32:413–417

    Article  CAS  Google Scholar 

  21. Hakim AJ, Grahame R (2003) A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain. Int J Clin Pract 57:163–166

    CAS  PubMed  Google Scholar 

  22. Cutolo M, Smith V (2013) Nailfold capillaroscopy and other methods to assess the microvasculopathy in systemic sclerosis. In: Hachulla E, Czirjak L (eds) Eular, textbook on systemic sclerosis. BMJ Publising Group, London, pp 129–138

    Google Scholar 

  23. Hirschl M, Hirschl K, Lenz M, Katzenschlager R, Hutter HP, Kundi M (2006) Transition from primary Raynaud’s phenomenon to secondary Raynaud’s phenomenon identified by diagnosis of an associated disease. Arthritis Rheum 54:1974–1981

    Article  Google Scholar 

  24. Leroux MB (2018) Erythromelalgia: a cutaneous manifestation of neuropathy? An Bras Dermatol 93:86–94

    Article  Google Scholar 

  25. Pascarella A, Provitera V, Lullo F, Stancanelli A, Saltalamacchia AM, Caporaso G, Nolano M (2016) Evidence of small fiber neuropathy in a patient with Ehlers-Danlos syndrome, hypermobility-type. Clin Neurophysiol 127:1914–1916

    Article  Google Scholar 

  26. Dean SM (2018) Cutaneous manifestations of chronic vascular disease. Prog Cardiovasc Dis 60:567–579

    Article  Google Scholar 

  27. Fraenkel L, Zhang Y, Chaisson CE, Maricq HR, Evans SR, Brand F, Wilson PWF, Felson DT (1999) Different factors influencing the expression of Raynaud’s phenomenon in men and women. Arthritis Rheum 42:306–310

    Article  CAS  Google Scholar 

  28. Freedman RR, Mayes MD (1996) Familial aggregation of primary Raynaud’s disease. Arhtritis Rheum 39:1189–1191

    Article  CAS  Google Scholar 

  29. Sivula A (1966) Vascular reactions in acrocyanosis. Angiology 17:269–274

    Article  CAS  Google Scholar 

  30. Manios Y, Moschonis G, Lambrinou GP, Tsoutsoulopoulou K, Binou P, Karachaliou A et al (2018) A systematic review of vitamin D status in southern European countries. Eur J Nutr 57:2001–2036

    Article  CAS  Google Scholar 

  31. Sideri V, Antonakos G, Fretzayas A, Attilakos A, Chrelias C, Papaevangelou V, Nicolaidou P, Papadopoulou A (2019) Hypovitaminosis D in healthy pregnant women and their newborns in Greece. Endocr Metab Immune Disord Drug Targets 19:159–165

    Article  CAS  Google Scholar 

  32. Rajaei A, Dehghan P, Amiri A (2017) Nailfold capillaroscopy in 430 patients with rheumatoid arthritis. Caspian J Intern Med 8:269–274

    PubMed  PubMed Central  Google Scholar 

  33. Wigley F, Cutollo M (2013) Raynaud’s phenomenon. In Eular. Textbook on systemic sclerosis. Hachulla E, Czirjak L (Eds), BMJ Publishing Group Ltd, pp 115–128

  34. Davis MD, O’Fallon WM, Rogers RS 3rd, Rooke TW (2000) Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol 136:330–336

    Article  CAS  Google Scholar 

  35. Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boirre G et al (2008) Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arhtritis Rheum 58:3902–3912

    Article  Google Scholar 

  36. Pauling JD, Reilly E, Smith T, Frech TM (2018) Evolving symptoms of Raynaud’s phenomenon in systemic sclerosis are associated with physician and patient-reported assessments of disease severity. Arthritis Care Res. https://doi.org/10.1002/acr.23729

    Article  Google Scholar 

Download references

Funding

The study was supported by the Hellenic Rheumatology Society.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Periklis Vounotrypidis.

Ethics declarations

Patients were asked to participate in this prospective observational study and written informed consent was obtained, according to the Declaration of Helsinki. The study was approved by the Hospital’s Ethical Committee.

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vounotrypidis, P., Pyrpasopoulou, A., Sakellariou, G.T. et al. Vascular acrosyndromes in young adult population. Definition of clinical symptoms and connections to joint hypermobility. Clin Rheumatol 38, 2925–2932 (2019). https://doi.org/10.1007/s10067-019-04627-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-019-04627-w

Keywords

Navigation